Angiogenesis inhibitors
Abstract
A method for treating an angiogenesis-related disorder. The method includes administrating to a subject in need thereof an effective amount of a compound of the formula: Each of Ar 1 , Ar 2 , and Ar 3 , independently, is phenyl, thienyl, furyl, pyrrolyl, pyridinyl, or pyrimidinyl; each of R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 , independently, is R, nitro, halogen, C(O)OR, C(O)SR, C(O)NRR′, (CH 2 ) m OR, (CH 2 ) m SR, (CH 2 ) m NRR′, (CH 2 ) m CN, (CH 2 ) m C(O)OR, (CH 2 ) m CHO, (CH 2 ) m CH═NOR, or R 1 and R 2 together, R 3 and R 4 together, or R 5 and R 6 together are O(CH 2 ) m O, in which each of R and R′, independently, is H or C 1 ˜C 6 alkyl; and m is 0, 1, 2, 3, 4, 5, or 6, and n is 0, 1, 2, or 3.
Claims
exact text as granted — not AI-modified1 - 15 . (canceled)
16 . A method for treating cancer, comprising administrating to a subject in need thereof an effective amount of a compound of the formula:
wherein
each of Ar 1 , Ar 2 , and Ar 3 , independently, is phenyl, thienyl, furyl, pyrrolyl, pyridinyl, or pyrimidinyl;
each of R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 , independently, is R, nitro, halogen, C(O)OR, C(O)SR, C(O)NRR′, (CH 2 ) m OR, (CH 2 ) m SR, (CH 2 ) m NRR′, (CH 2 ) m CN, (CH 2 ) m C(O)OR, (CH 2 ) m CHO, (CH 2 ) m CH═NOR, or R 1 and R 2 together, R 3 and R 4 together, or R 5 and R 6 together are O(CH 2 ) m O, in which each of R and R′, independently, is H or C 1 ˜C 6 alkyl; and m is 0, 1, 2, 3, 4, 5, or 6, and n is 0, 1, 2, or 3.
17 . The method of claim 16 , wherein Ar 1 is phenyl.
18 . The method of claim 17 , wherein Ar 2 is furyl.
19 . The method of claim 18 , wherein Ar 2 is 5′-furyl.
20 . The method of claim 19 , wherein Ar 3 is phenyl.
21 . The method of claim 20 , wherein each of R 1 , R 2 , R 5 , and R 6 is H.
22 . The method of claim 21 , wherein n is 1.
23 . The method of claim 22 , wherein one of R 3 and R 4 is substituted at position 2 of furyl.
24 . The method of claim 23 , wherein one of R 3 and R 4 is H, and the other is CH 2 OH.
25 . The method of claim 16 , wherein Ar 2 is furyl.
26 . The method of claim 25 , wherein Ar 2 is 5′-furyl.
27 . The method of claim 26 , wherein one of R 3 and R 4 is substituted at position 2 of furyl.
28 . The method of claim 16 , wherein Ar 3 is phenyl.
29 . The method of claim 28 , wherein n is 1.
30 . The method of claim 16 , wherein the cancer is lung cancer.
31 . The method of claim 30 , wherein Ar 1 is phenyl.
32 . The method of claim 31 , wherein Ar 2 is furyl.
33 . The method of claim 32 , wherein Ar 2 is 5′-furyl.
34 . The method of claim 33 , wherein Ar 3 is phenyl.
35 . The method of claim 34 , wherein each of R 1 , R 2 , R 5 , and R 6 is H.
36 . The method of claim 35 , wherein n is 1.
37 . The method of claim 36 , wherein one of R 3 and R 4 is substituted at position 2 of furyl.
38 . The method of claim 37 , wherein one of R 3 and R 4 is H, and the other is CH 2 OH.
39 . The method of claim 30 , wherein Ar 2 is furyl.
40 . The method of claim 39 , wherein Ar 2 is 5′-furyl.
41 . The method of claim 40 , wherein one of R 3 and R 4 is substituted at position 2 of furyl.
42 . The method of claim 30 , wherein Ar 3 is phenyl.
43 . The method of claim 42 , wherein n is 1.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.